Public limited company · Oslo
AQUA BIO TECHNOLOGY ASA
ActiveResearch and experimental development on natural sciences and engineering (72.100)
The life line 2004–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 7.5m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
AQUA BIO TECHNOLOGY ASA is a public limited company in Oslo, founded in 2004, in the industry research and experimental development on natural sciences and engineering. The chief executive is Kristian Flaten, and the chair of the board is Roger Sebastian Sedal. In 2025 the company had NOK 7.5m in operating revenue and a net profit of NOK −16.2m; the group had revenue of NOK 7.5m. The largest owner is PJUR EIENDOM AS with 5.6%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 29 Jul 2026
- Annual accounts filed 2024 → 2025
- Godkjent årsregnskap
- Changed purpose or activity
- New articles of association 17 Jun 2026
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteOperating loss three years running, 2023–2025
- NoteNegative equity in 2025
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 7.5m in 2025
Revenue
NOK 7.5m
+503.8% from 2024
20232025
Operating profit
NOK −12.6m
+80.0% from 2024
20232025
Net profit
NOK −16.2m
+93.0% from 2024
20232025
Equity
NOK −489k
−108.0% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 42%
- Depreciation 0%
- Other operating costs 204%
- Not specified in the source 21%
Costs exceeded revenue: the operating result was NOK −12.6m.
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 0.0%
- AQUA BIO TECHNOLOGY ASA, 2025
- Industry median, assumed: NOK 1.5m · −4.4% · 48.9% · +3.0%
Equity NOK −489k0% of the assets (NOK 130.0m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 694 companies in 72.100 Research and experimental development on natural sciences and engineering, not stated by the source.
Finances
§ 06 Accounts
22 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 7,532 | 1,248 | 516 | |
| Operating profit | −12,552 | −62,846 | −22,263 | |
| Profit before tax | −16,215 | −233,286 | −37,050 | |
| Net profit | −16,215 | −233,164 | −36,889 | |
| Total assets | 130,019 | 149,709 | 99,622 | |
| Equity | −489 | 6,147 | 62,723 | |
| Liabilities | 130,508 | 143,563 | 36,900 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 22 years →
Management and ownership
§ 07 Officers
7 officers now
- BDO ASAuditor since 2025
- Kristian FlatenChief executive since 2025
- AZETS INSIGHT ASAccountant
- Roger Sebastian SedalChair of the board since 2025
- Odd Terje BlyttBoard member since 2024
- Sofie Aimee SiemBoard member since 2024
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · All 7 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
2 valid powers of attorney
May sign for the company:
Daglig leder og styrets leder i fellesskap eller to styremedlemmer i fellesskap.
Power of procuration:
Daglig leder alene.
The board has 2 authorisations in force now: capital increase, until 30 Jun 2027; capital increase, until 30 Jun 2027.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 16 Nov 2026
Management and ownership
§ 09 Owners
227 shareholders · largest 5.6%
| Owner | Share |
|---|---|
| PJUR EIENDOM AS | 5.6% |
| INTELCO AS | 5.6% |
| RH INDUSTRI AS | 5.4% |
| 224 others | 83.4% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 227 owners →
Management and ownership
§ 10 Group
7 subsidiaries
- COVER BRANDS AS100%
- COSMED BEAUTY AS100%
- OVALEN AS100%
- + 4 other subsidiaries
The group 2025: operating revenue NOK 7.5m (−93.0%).
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
Holds shares in 1 company
Source: the Tax Administration's Register of Shareholders, read 31 Jul 2026 · The whole portfolio →
Management and ownership
§ 12 Network
31 connections
- Person
- Company
3 people link AQUA BIO TECHNOLOGY ASA to 21 other companies: Odd Terje Blytt 11, Roger Sebastian Sedal 11 and Kristian Flaten 5.
Source: the Brønnøysund Register Centre, read 22 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
126 since 2015
Events per year
20152026
Since 2015: 221 announcements, 4 register changes and 6 new and 3 former owners. Most happened in 2024 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 126 events →
Events and registers
§ 14 Notices
221, latest 28 Jul 2026
- Godkjente årsregnskap
- Vedtektsfestet formål
- Vedtektsdato
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 221 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 9 Mar 2004
- VATRegistered
- The Register of Business EnterprisesRegistered 9 Mar 2004
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Utvikle og markedsføre egne patenter samt produkter og teknologi utviklet på bakgrunn av slike patenter. Dette skal skje ved egen forskning og ved samarbeidende institusjoner, både nasjonalt og internasjonalt. Ytterligere er selskapets formål å utvikle programvare til logistikkbransjen samt kjøpe og selge frakt, tollbehandling og logistikktjenester. Selskapet kan også drive med relatert virksomhet. Selskapet kan dessuten investere i andre virksomheter både i innland og utland.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 72.100
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
7 questions
- Who is the chief executive of AQUA BIO TECHNOLOGY ASA?
Kristian Flaten, since 2025. § 07 - Who owns AQUA BIO TECHNOLOGY ASA?
227 shareholders. The largest is PJUR EIENDOM AS with 5.6%, INTELCO AS with 5.6% and RH INDUSTRI AS with 5.4%. § 09 - What was the revenue in 2025?
NOK 7.5m in the company and NOK 7.5m in the group. § 06 - Who can sign for AQUA BIO TECHNOLOGY ASA?
Daglig leder og styrets leder i fellesskap eller to styremedlemmer i fellesskap. § 08 - Who is the auditor?
BDO AS, from 8 Aug 2025. § 07 - Where is AQUA BIO TECHNOLOGY ASA based?
Karenslyst allé 10, 0278 Oslo. - When was AQUA BIO TECHNOLOGY ASA founded?
10 Feb 2004, registered in the Register of Business Enterprises 9 Mar 2004. § 16
The answers come from the sections linked to, with their sources.